Polymers for Mucoadhesive Drug Delivery System: A Current Status

REFERENCES

• V. Agarwal, and B. Mishra. (1999). Design, development, and biopharmaceutical properties of buccoadhesive compacts of pentazocine. Drug Dev. Ind. Pharm 25:701–709.
   PubMed Web of Science ®Google Scholar
• A. Ahuja, M. Dogra, and S. P. Agarwal. (1995). Development of buccal tablets of diltiazem hydrochloride. Indian J. Pharm. Sci 57:26–30.
   Google Scholar
• A. Ahuja, R. K. Khar, and J. Ali. (1997a). Mucoadhesive drug delivery _systems. Drug. Dev. Ind. Pharm 23 (5):489–515.
   Web of Science ®Google Scholar
• A. Ahuja, R. K. Khar, and J. Ali. (1997b). Mucoadhesive drug delivery systems. Drug Dev. Ind. Pharm 19:1–31.
   Google Scholar
• A. Ahuja, R. K. Khar, and R. Chaudhry. (1998). Evaluation of buccoadhesive metronidazole tablets: Microbiological response. Pharmazie 53:264–267.
   PubMed Web of Science ®Google Scholar
• J. Akbari, A. Nokhodchi, D. Farid, M. Adrangui, M. R. Siahi-Shadbad, and M. Saeedi. (2004). Development and evaluation of buccoadhesive propranolol hydrochloride tablet formulations: Effect of fillers. IL Farmaco 59:155–161.
   PubMedGoogle Scholar
• J. Ali, R. K. Khar, and A. Ahuja. (1998). Formulation and characterisation of a buccoadhesive erodible tablet for the treatment of oral lesions. Pharmazie 53:329–334.
   PubMed Web of Science ®Google Scholar
• J. Ali, R. Khar, A. Ahuja, and R. Kalra. (2002). Buccoadhesive erodible disk for treatment of oro-dental infections: design and characterization. Int. J. Pharm 238:93–103.
   PubMed Web of Science ®Google Scholar
• A. Allen, R. H. Pain, and T. R. Robson. (1976). Model for the structure of the gastric mucous gel. Nature 264:88–89.
   PubMed Web of Science ®Google Scholar
• H. H. Alur, J. D. Beal, S. I. Pather, A. K. Mitra, and T. P. Johnston. (1999). Evaluation of a novel, natural oligosaccharide gum as a sustained-release and mucoadhesive component of calcitonin buccal tablets. J. Pharm. Sci 88:1313–1319.
   PubMed Web of Science ®Google Scholar
• H. H. Alur, S. I. Pather, A. K. Mitra, and T. P. Johnston. (1999a). Evaluation of the gum from Hakea gibbosa as a sustained-release and mucoadhesive component in buccal tablets. Pharm. Dev. Technol 4:347–358.
   PubMed Web of Science ®Google Scholar
• H. H. Alur, S. I. Pather, A. K. Mitra, and T. P. Johnston. (1999b). Transmucosal sustained-delivery of chlorpheniramine maleate in rabbits using a novel, natural mucoadhesive gum as an excipient in buccal tablets. Int. J. Pharm 188:1–10.
   PubMed Web of Science ®Google Scholar
• D. Ameye, J. Voorspoels, P. Foreman, J. Tsai, P. Richardson, S. Geresh, and J. P. Remon. (2002). Ex vivo bioadhesion and in vivo testosterone bioavailability study of different bioadhesive formulations based on starch-g-poly (acrylic acid) copolymers and starch/poly (acrylic acid) mixtures. J. Control. Release 79:173–182.
   PubMed Web of Science ®Google Scholar
• R. Anders, and H. P. Merkle. (1989). Evaluation of laminated muco-adhesive patches for buccal drug delivery. Int. J. Pharm 49:231–240.
   Web of Science ®Google Scholar
• S. Anlar, Y. Çapan, O. Güven, A. Gögüs, T. Dalkara, and A. A. Hıncal. (1994). Formulation and in vitro/in vivo evaluation of buccoadhesive morphine sulfate tablets. Pharm. Res 11:231–236.
   PubMed Web of Science ®Google Scholar
• M. Artusi, P. Santi, P. Colombo, and H. E. Junginger. (2003). Buccal delivery of thiocolchicoside: in vitro and in vivo permeation studies. Int. J. Pharm 250:203–213.
   PubMed Web of Science ®Google Scholar
• G. S. Asane, Y. M. Rao, A. V. Bhosale, and S. A. Nirmal. (2007). Mucoadhesive gastro intestinal drug delivery system: An overview. Indian Drugs 44 (8):577–584.
   Google Scholar
• R. M. Barrer, J. A. Barrie, and P. S. L. Wong. (1968). The diffusion and solution of gases in highly cross linked copolymers. Polymer 9:609–627.
   Web of Science ®Google Scholar
• L. Bénès, B. Claustrat, F. Horrière, M. Geoffriau, J. Konsil, K. A. Parrott, G. DeGrande, R. L. McQuinn, and J. W. Ayres. (1997). Transmucosal, oral controlled-release, and transdermal drug administration in human subjects: A crossover study with melatonin. J. Pharm. Sci 86:1115–1119.
   PubMed Web of Science ®Google Scholar
• A. Bernkop-Schnürch, M. Hornof, and T. Zoidl. (2003). Thiolated polymers-Thiomers: Modification of chitosan with 2-iminothiolane. Int. J. Pharm 260:229–237.
   PubMed Web of Science ®Google Scholar
• E. Beyssac, F. Touaref, M. Meyer, L. Jacob, P. Sandouk, and J. M. Aiache. (1998). Bioavailability of morphine after administration of a new bioadhesive buccal tablet. Biopharm. Drug Dispos 19:401–405.
   PubMed Web of Science ®Google Scholar
• F. Bombart. (1992). Aqueous vaginal douche compositions. WO 9210998 A1 19920709.
   Google Scholar
• P. Bottenberg, R. Cleymaet, K. Röhrkasten, and F. Lampert. (2000). Microhardness changes in surface enamel after application of bioadhesive fluoride tablets in situ. Clin. Oral Investig 4:153–156.
   PubMedGoogle Scholar
• S. Bouckaert, R. A. Lefebvre, F. Colardyn, and J. P. Remon. (1993). Influence of the application site on bioadhesion and slow release characteristics of a bioadhesive buccal slow-release tablet of miconazole. Eur. J. Clin. Pharmacol 44:331–335.
   PubMed Web of Science ®Google Scholar
• S. Bouckaert, R. A. Lefebvre, and J. P. Remon. (1993). In vitro/in vivo correlation of the bioadhesive properties of a buccal bioadhesive miconazole slow release tablet. Pharm. Res 10:853–856.
   PubMed Web of Science ®Google Scholar
• S. Bouckaert, and J. P. Remon. (1993). In-vitro bioadhesion of a buccal, miconazole slow-release tablet. J. Pharm. Pharmacol 45:504–507.
   PubMed Web of Science ®Google Scholar
• S. Bouckaert, H. Schautteet, R. A. Lefebvre, J. P. Remon, and R. van Clooster. (1992). Comparison of salivary miconazole concentrations after administration of a bioadhesive slow release buccal tablet and an oral gel. Eur. J. Clin. Pharmacol 43:137–140.
   PubMed Web of Science ®Google Scholar
• I. M. Brook, G. T. Tucker, E. C. Tuckley, and R. N. Boyes. (1989). A lignocaine patch for dental analgesia safety and early pharmacology. J. Control. Release 10:183–188.
   Web of Science ®Google Scholar
• C. Callens, E. Pringels, and J. P. Remon. (2003). Influence of multiple nasal administrations of bioadhesive powders on the insulin bioavailability. Int. J. Pharm 250:415–422.
   PubMed Web of Science ®Google Scholar
• C. Callens, and J. P. Remon. (2000). Evaluation of starch–maltodextrin–Carbopol 974 P mixtures for the nasal delivery of insulin in rabbits. J. Control. Release 66:215–220.
   PubMed Web of Science ®Google Scholar
• M. Calonge. (2001). The treatment of dry eye. Surv. Ophthalmol 45 (2):S227–S239.
   PubMedGoogle Scholar
• J. Cassidy, B. Berner, K. Chan, V. John, S. Toon, B. Holt, and M. Rowland. (1993). Human transbuccal absorption of diclofenac sodium from a prototype hydrogel delivery device. Pharm. Res 10:126–129.
   PubMed Web of Science ®Google Scholar
• N. Çelebi, and O. Kiσlal. (1995). Development and evaluation of a buccoadhesive propranolol tablet formulation. Pharmazie 50:470–472.
   PubMed Web of Science ®Google Scholar
• G. C. Ceschel, P. Maffei, S. L. Biogia, and C. Ronchi. (2001). Design and evaluation of buccal adhesive hydrocortisone acetate (HCA) tablets. Drug Deliv 8:161–171.
   PubMed Web of Science ®Google Scholar
• G. C. Ceschel, P. Maffei, A. Sforzini, S. Lombardi Borgia, A. Yasin, and C. Ronchi. (2002). In vitro permeation through porcine buccalmucosa of caffeic acid phenetyl ester (CAPE) from a topical mucoadhesive gel containing propolis. Fitoterapia 73 (1):S44–S52.
   PubMedGoogle Scholar
• H. S. Ch'ng, H. Park, P. Kelly, and J. R. Robinson. (1985). Bioadhesive polymers as platforms for oral controlled drug delivery II: Synthesis and evaluation of some swelling water-insoluble bioadhesive polymers. J. Pharm. Sci 74 (4):399–405.
   PubMed Web of Science ®Google Scholar
• S. C. Chang, D. S. Chien, H. Bundgaard, and V. H. L. Lee. (1988). Relative effectiveness of pro-drug and viscous approaches in maximizing the ratio of ocular to systemic absorption of topically applied timolol. Exp. Eye Res 46:56–69.
   Google Scholar
• R. B. Chary, G. Vani, and Y. M. Rao. (1999). In vitro and In vivo adhesion testing of mucoadhesive drug delivery systems. Drug Dev. Ind. Pharm 25 (5):685–690.
   PubMed Web of Science ®Google Scholar
• J. L. Chen, and G. N. Cyr. (1993). Composition producing adhesion through hydration, In R. S. Manly (Eds.), Adhesion in biological system (pp. 163–181). New York: Academic Press.
   Google Scholar
• Y. Cheng, P. Watts, M. Hinchcliffe, R. Hotchkiss, R. Nankervis, N. F. Faraj, A. Smith, S. S. Davis, and L. Illum. (2002). Development of a novel nasal nicotine formulation comprising an optimal pulsatile and sustained plasma nicotine profile for smoking cessation. J. Control. Release 79:243–254.
   PubMed Web of Science ®Google Scholar
• D. E. ChickeringIII, and E. Mathiowitz. (1999). Bioadhesive drug delivery systems: Fundamentals, novel approaches, and developments, In E. Mathiowitz, D. E. ChickeringIII, and C. M. Lehr (Eds.), Definitions mechanisms and theories of bioadhesion, (pp. 1–10). New York: Marcel Dekker.
   Google Scholar
• H. -G. Choi, J. -H. Jung, C. S. Yong, C. -D. Rhee, M. -K. Lee, J. -H. Han, K. -M. Park, and C. -K. Kim. (2000). Formulation and in vivo evaluation of omeprazole buccal adhesive tablet. J. Control. Release 68:405–412.
   PubMed Web of Science ®Google Scholar
• H. -G. Choi, and C. -K. Kim. (2000). Development of omeprazole buccal adhesive tablets with stability enhancement in human saliva. J. Control. Release 68:397–404.
   PubMed Web of Science ®Google Scholar
• K. P. R. Chowdary, and L. Srinivas. (2000). Mucoadhesive drug delivery systems: A review of current status. Indian Drugs 37 (9):400–406.
   Google Scholar
• S. S. Chrai, and J. R. Robinson. (1974). Ocular evaluation of methylcellulose vehicle in albino rabbits. J. Pharm. Sci 63:1218–1223.
   PubMed Web of Science ®Google Scholar
• M. -K. Chun, B. -T. Kwak, and H. -K. Choi. (2003). Preparation of buccal patch composed of carbopol, poloxamer and hydroxypropyl methylcellulose. Arch. Pharm. Res 26:973–978.
   PubMed Web of Science ®Google Scholar
• A. E. Collins, and P. B. Deasy. (1990). Bioadhesive lozenge for the improved delivery of cetylpyridinium chloride. J. Pharm. Sci 79:116–119.
   PubMed Web of Science ®Google Scholar
• H. Critchley, S. S. Davis, N. F. Farraj, and L. Illum. (1994). Nasal absorption of desmopressin in rats and sheep, effect of a bioadhesive microsphere delivery system. J. Pharm. Pharmacol 46:651–656.
   PubMed Web of Science ®Google Scholar
• Z. Cui, and R. J. Mumper. (2002a). Bilayer films for mucosal (genetic) immunization via the buccal route in rabbits. Pharm. Res 19:947–953.
   PubMed Web of Science ®Google Scholar
• Z. Cui, and R. J. Mumper. (2002b). Buccal transmucosal delivery of calcitonin in rabbits using thin-film composites. Pharm. Res 19:1901–1906.
   PubMed Web of Science ®Google Scholar
• M. Diarra, G. Pourroy, C. Boymond, and D. Muster. (2003). Fluoride controlled release tablets for intrabuccal use. Biomaterials 24:1293–1300.
   PubMed Web of Science ®Google Scholar
• M. Diarra, G. Pourroy, D. Muster, M. Zingraff, and C. Boymond. (1998). Elaboration and evaluation of an intraoral controlled release delivering system. Biomaterials 19:1523–1527.
   PubMed Web of Science ®Google Scholar
• G. A. Digenis, D. Nosek, F. Mohammadi, N. B. Darwazeh, H. S. Anwar, and P. M. Zavos. (1999). Novel vaginal controlled-delivery systems incorporating coprecipitates of nonoxynol-9. Pharm. Dev. Technol 4:421–430.
   PubMed Web of Science ®Google Scholar
• M. Dittgen, M. Durrani, and K. Lehmann. (1997). Acrylic polymers. A review of pharmaceutical applications. STP Pharma. Sci 7:403–437.
   Google Scholar
• B. Dortunç, L. Özer, and N. Uyanik. (1998). Development and in vitro evaluation of a buccoadhesive pindolol tablet formulation. Drug Dev. Ind. Pharm 24:281–288.
   PubMed Web of Science ®Google Scholar
• D. Duchene, F. Touchard, and N. A. Peppas. (1988). Pharmaceutical and medical aspects of bioadhesive systems for drug administration. Drug Dev. Ind. Pharm 14:283–318.
   Web of Science ®Google Scholar
• A. El-Kamel, M. Sokar, V. Naggar, and S. Al Gamal. (2002). Chitosan and sodium alginate-based bioadhesive vaginal tablets. AAPS Pharm. Sci 44. (Article)
   Google Scholar
• G. M. Gaeta, F. Gombos, F. Femiano, C. Battista, P. Minghetti, L. Montanari, R. A. Satriano, and G. Argenziano. (2000). Acitretin and treatment of the oral leucoplakias. A model to have an active molecules release. J. Eur. Acad. Dermatol. Venereol 14:473–478.
   PubMed Web of Science ®Google Scholar
• A. Garcia-Arieta, S. Torrado-Santiago, L. Goya, and J. J. Torrado. (2001). Spray-dried powders as nasal absorption enhancers of cyanocobalamin. Biol. Pharm. Bull 24:1411–1416.
   PubMed Web of Science ®Google Scholar
• S. Geresh, G. Y. Gdalevsky, I. Gilboa, J. Voorspoels, J. P. Remon, and J. Kost. (2004). Bioadhesive grafted starch copolymers as platforms for peroral drug delivery: a study of theophylline release. J. Control. Release 94:391–399.
   PubMed Web of Science ®Google Scholar
• P. Giunchedi, C. Juliano, E. Gavini, M. Cossu, and M. Sorrenti. (2002). Formulation and in vivo evaluation of chlorhexidine buccal tablets prepared using drug loaded chitosan microspheres. Eur. J. Pharm. Biopharm 53:233–239.
   PubMed Web of Science ®Google Scholar
• J. L. Greaves, and C. G. Wilson. (1993). Treatment of diseases of the eye with mucoadhesive delivery systems. Adv. Drug Deliv. Rev 11:349–383.
   Web of Science ®Google Scholar
• J. -H. Guo. (1994). Bioadhesive polymer buccal patches for buprenorphine controlled delivery: Formulation, in-vitro adhesion and release properties. Drug Dev. Ind. Pharm 20:2809–2821.
   Web of Science ®Google Scholar
• J. -H. Guo, and K. M. Cooklock. (1996). The effects of backing materials and multilayered systems on the characteristics of bioadhesive buccal patches. J. Pharm. Pharmacol 48:255–257.
   PubMed Web of Science ®Google Scholar
• R. Gurny, J. M. Meyer, and N. A. Peppas. (1984). Bioadhesive intraoral release systems: Design testing and analysis. Biomaterials 5:336–340.
   PubMed Web of Science ®Google Scholar
• R. Gurny, and N. A. Peppas. (1990). Semisolid dosage forms as buccal bioadhesives. In V. Lenaerts, and R. Gurny (Eds.). Bioadhesive drug delivery system (pp. 133–163). Boca RatanFL: CRC press.
   Google Scholar
• M. K. Gutniak, H. Larsson, S. J. Heiber, O. T. Juneskans, J. J. Holst, and B. Ahrén. (1996). Potential therapeutic levels of glucagon-like peptide I achieved in humans by a buccal tablet. Diabetes Care 19:843–848.
   PubMed Web of Science ®Google Scholar
• M. K. Gutniak, H. Larsson, S. W. Sanders, O. Juneskans, J. J. Holst, and B. Ahrén. (1997). GLP-1 tablet in type 2 diabetes in fasting and postprandial conditions. Diabetes Care 20:1874–1879.
   PubMed Web of Science ®Google Scholar
• J. H. Hamman, M. Stander, and A. F. Kotze. (2002). Effect of the degree of quaternisation of N-trimethyl chitosan chloride on absorption enhancement: in vivo evaluation in rat nasal epithelia. Int. J. Pharm 232:235–242.
   PubMed Web of Science ®Google Scholar
• R. Y. Han, J. Y. Fang, K. C. Sung, and O. Y. P. Hu. (1999). Mucoadhesive buccal disks for novel nalbuphine prodrug controlled delivery: Effect of formulation variables on drug release and mucoadhesive performance. Int. J. Pharm 177:201–209.
   PubMed Web of Science ®Google Scholar
• A. S. Harris, M. Ohlin, E. Svensson, S. Lethagen, and I. M. Nilsson. (1989). Effect of viscosity on the pharmacokinetics and biological response to intranasal desmopressin. J. Pharm. Sci 78:470–471.
   PubMed Web of Science ®Google Scholar
• D. Harris, and J. R. Robinson. (1992). Drug delivery via the mucous membranes of the oral cavity. J. Pharm. Sci 81:1–10.
   PubMed Web of Science ®Google Scholar
• E. E. Hassan, and J. M. Gallo. (1990). Simple rheological method for the in vitro assessment of mucin-polymer bioadhesive bond strength. Pharm. Res 7:491–498.
   PubMed Web of Science ®Google Scholar
• G. Honda. (1998). Vaginal lubricant pastes or gels containing hyaluronic acid. JP 10182435:
   Google Scholar
• E. A. Hosny, S. A. Elkheshen, and S. I. Saleh. (2002). Buccoadhesive tablets for insulin delivery: In-vitro and in-vivo studies. Boll. Chim. Farm 141:210–217.
   PubMedGoogle Scholar
• H. -W. Hui, and J. R. Robinson. (1985). Ocular drug delivery of progesterone using a bioadhesive polymer. Int. J. Pharm 26:203–213.
   Web of Science ®Google Scholar
• K. Ikeda, K. Murata, M. Kobayashi, and K. Noda. (1992). Enhancement of bioavailability of dopamine via nasal route in beagle dogs. Chem. Pharm. Bull 40:2155–2158.
   PubMed Web of Science ®Google Scholar
• G. İkinci, Y. C. Çapan, S. S. Enel, E. Alaaddinoγlu, T. Dalkara, and A. A. Hıncal. (2000). In vitro/in vivo studies on a buccal bioadhesive tablet formulation of carbamazepine. Pharmazie 55:762–765.
   PubMed Web of Science ®Google Scholar
• G. İkinci, S. Senel, H. Akincibay, S. Kass, S. Ercis, C. G. Wilson, and A. A. Hincal. (2002). Effect of chitosan on a periodontal pathogen Porphyromonas gingivalis. Int. J. Pharm 235:121–127.
   PubMed Web of Science ®Google Scholar
• G. İkinci, S. Senel, C. G. Wilson, and M. Sumnu. (2004). Development of a buccal bioadhesive nicotine tablet formulation for smoking cessation. Int. J. Pharm 277:173–178.
   PubMed Web of Science ®Google Scholar
• R. Ilango, S. Kavimani, A. R. Mullaicharam, and B. Jayakar. (1997). Invitro studies on buccal strips of glibenclamide using chitosan. Indian J. Pharm. Sci 59:232–235.
   Google Scholar
• L. Illum, A. N. Fisher, I. Jabbal-Gill, and S. S. Davis. (2001). Bioadhesive starch microspheres and absorption enhancing agents act synergistically to enhance the nasal absorption of polypeptides. Int. J. Pharm 222:109–119.
   PubMed Web of Science ®Google Scholar
• L. Illum, P. Watts, A. N. Fisher, M. Hinchcliffe, H. Norbury, I. Jabbal-Gill, R. Nankervis, and S. S. Davis. (2002). Intranasal delivery of morphine. J. Pharmacol. Exp. Ther 301:391–400.
   PubMed Web of Science ®Google Scholar
• M. Ishida, Y. Machida, N. Nambu, and T. Nagai. (1981). New mucosal dosage form of insulin. Chem. Pharm. Bull. (Tokyo) 29:810–816.
   PubMed Web of Science ®Google Scholar
• F. Ishikawa, M. Murano, M. Hiraishi, T. Yamaguchi, I. Tamai, and A. Tsuji. (2002). Insoluble powder formulation as an effective nasal drug delivery system. Pharm. Res 19:1097–1104.
   PubMed Web of Science ®Google Scholar
• A. C. Jain, B. J. Aungst, and M. C. Adeyeye. (2002). Development and in vivo evaluation of buccal tablets prepared using danazol-sulfobutylether 7 h-cyclodextrin (SBE 7) complexes. J. Pharm. Sci 91:1659–1668.
   PubMed Web of Science ®Google Scholar
• S. Jay, W. Fountain, Z. Cui, and R. J. Mumper. (2002). Transmucosal delivery of testosterone in rabbits using novel bi-layer mucoadhesive wax-film composite disks. J. Pharm. Sci 91:2016–2025.
   PubMed Web of Science ®Google Scholar
• N. R. Jimenez-Castellanos, H. Zia, and C. T. Rhodes. (1993). Mucoadhesive drug delivery systems. Drug. Dev. Ind. Pharm 19:143–194.
   Web of Science ®Google Scholar
• D. S. Jones, A. F. Brown, A. D. Woolfson, A. C. Dennis, L. J. Matchett, and S. E. J. Bell. (2000). Examination of the physical state of chlorhexidine within viscoelastic, bioadhesive semisolids using Raman spectroscopy. J. Pharm. Sci 89:563–571.
   PubMed Web of Science ®Google Scholar
• D. S. Jones, C. R. Irwin, A. D. Woolfson, J. Djokic, and V. Adams. (1999). Physicochemical characterization and preliminary in vivo efficacy of bioadhesive, semisolid formulations containing flurbiprofen for the treatment of gingivitis. J. Pharm. Sci 88:592–598.
   PubMed Web of Science ®Google Scholar
• D. S. Jones, and N. J. Medlicott. (1995). Casting solvent controlled release of chlorhexidine from ethylcellulose films prepared by solvent evaporation. Int. J. Pharm 114:257–261.
   Web of Science ®Google Scholar
• D. S. Jones, A. D. Woolfson, and A. F. Brown. (1997). Textural analysis and flow rheometry of novel, bioadhesive antimicrobial oral gels. Pharm. Res 14:450–457.
   PubMed Web of Science ®Google Scholar
• D. S. Jones, A. D. Woolfson, A. F. Brown, W. A. Coulter, C. McClelland, and C. R. Irwin. (2000). Design, characterisation and preliminary clinical evaluation of a novel mucoadhesive topical formulation containing tetracycline for the treatment of periodontal disease. J. Control. Release 67:357–368.
   PubMed Web of Science ®Google Scholar
• D. S. Jones, A. D. Woolfson, J. Djokic, and W. A. Coulter. (1996). Development and mechanical characterization of bioadhesive semisolid, polymeric systems containing tetracycline for the treatment of periodontal diseases. Pharm. Res 13:1734–1738.
   PubMed Web of Science ®Google Scholar
• M. Jug, and M. Bećirević-Laćan. (2004). Influence of hydroxypropyl-β-cyclodextrin complexation on piroxicam release from buccoadhesive tablets. Eur. J. Pharm. Sci 21:251–260.
   PubMed Web of Science ®Google Scholar
• K. R. Kamath, and K. Park. (1994). Mucosal adhesive preparations, in J. Swarbrick, and J. C. Boylan (Eds.). Encyclopedia of pharmaceutical technology (Vol. 10, p. 133). New York: Marcel Dekker.
   Google Scholar
• I. K. Kaur, and R. Smita. (2002). Penetration enhancers and ocular bioadhesive: Two new avenues for opthalmic drug delivery. Drug Dev. Ind. pharm 28:353–369.
   PubMed Web of Science ®Google Scholar
• R. Khanna, S. P. Agrawal, and A. Ahuja. (1998). Mucoadhesive buccal drug delivery: A Potential Alternative to conventional therapy. Indian J. Pharm. Sci 60 (1):1–11.
   Google Scholar
• Y. S. R. Krishnaiah, Rao Kondala, B. Rama, Y. V. Prasad, and S. Satyanarayana. (1998). Gamma scintigraphy: An imaging technique for non-invasive in vivo evaluation of oral dosage forms. Indian Drugs 35 (7):387–398.
   Google Scholar
• R. Krisnamoorthy, and A. K. Mitra. (1993). Mucoadhesive polymers inocular drug delivery. In A. K. Mitra (Ed.). Opthalmic drug delivery systems (pp. 199–221). New York: Marcel Dekker.
   Google Scholar
• M. E. Kuipers, J. Heegsma, H. I. Bakker, D. K. F. Meijer, P. J. Swart, E. W. Frijlink, A. C. Eissens, H. G. de Vries-Hospers, and J. J. M. van den Berg. (2002). Design and fungicidal activity of mucoadhesive lactoferrin tablets for the treatment of oropharyngeal candidosis. Drug Deliv 9:31–38.
   PubMed Web of Science ®Google Scholar
• V. Kumar, and G. S. Banker. (1993). Chemically modified cellulose polymers. Drug Dev. Ind. Pharm 19:1–31.
   Web of Science ®Google Scholar
• N. Langoth, J. Kalbe, and A. Bernkop-Schnürch. (2003). Development of buccal drug delivery systems based on a thiolated polymer. Int. J. Pharm 252:141–148.
   PubMed Web of Science ®Google Scholar
• C. A. Le Bourlais, L. Treupel-Acar, C. T. Rhodes, P. A. Sado, and R. Leverge. (1995). New opthalmic drug delivery systems. Drug Dev. Ind. Pharm 21:19–59.
   Web of Science ®Google Scholar
• C. Le Bourlais, L. Acar, H. Zia, P. A. Sado, T. Needham, and R. Leverge. (1998). Ophthalmic drug delivery systems—recent advances. Prog. Retin. Eye Res 17:33–58.
   PubMed Web of Science ®Google Scholar
• J. W. Lee, J. H. Park, and J. R. Robinson. (2000). Bioadhesive based dosage forms: The next generation. J. Pharm. Sci 89 (7):850–866.
   PubMed Web of Science ®Google Scholar
• V. H. L. Lee, and J. R. Robinson. (1986). Review: Topical ocular drug delivery: Recent developments and future challenges. J. Ocul. Pharmacol 2:67–108.
   PubMedGoogle Scholar
• C. M. Lehr, F. C. G. Poelma, H. E. Junginger, and J. J. Tukker. (1991). An estimate of turnover time of intestinal mucus gel layer in the rats, in situ loop. Int. J. Pharm 70:235–240.
   Web of Science ®Google Scholar
• C. Li, P. P. Bhatt, and T. P. Johnston. (1996). In vitro release and permeation of oxytocin from a mucoadhesive buccal patch. Pharm. Dev. Tech 1:357–364.
   PubMedGoogle Scholar
• C. Li, P. P. Bhatt, and T. P. Johnston. (1997). Transmucosal delivery of oxytocin to rabbits using a mucoadhesive buccal patch. Pharm. Dev. Tech 2:265–274.
   PubMedGoogle Scholar
• C. Li, R. L. Koch, V. A. Raul, P. P. Bhatt, and T. P. Johnston. (1997). Absorption of thyrotropin-releasing hormone in rats using a mucoadhesive buccal patch. Drug Dev. Ind. Pharm 23:239–246.
   Web of Science ®Google Scholar
• S. T. Lim, B. Forbes, G. P. Martin, and M. B. Brown. (2001). In vivo and in vitro characterization of novel microparticulates based on hyaluronan and chitosan hydroglutamate. AAPS Pharm. Sci. Tech., 2, (Article 20).
   Google Scholar
• S. T. Lim, G. P. Martin, D. J. Berry, and M. B. Brown. (2000). Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan. J. Control. Release 66:281–292.
   PubMed Web of Science ®Google Scholar
• T. Loftsson, H. Gudmundsdottir, J. F. Sigurjonsdottir, H. H. Sigurdsson, S. D. Sigfusson, M. Masson, and E. Stefansson. (2001). Cyclodextrin solubilization of benzodiazepines: Formulation of midazolam nasal spray. Int. J. Pharm 212:29–40.
   PubMed Web of Science ®Google Scholar
• M. A. Longer, H. S. Ch'ng, and J. R. Robinson. (1985). Bioadhesive polymers as platforms for oral controlled drug delivery. III. Oral delivery of Chlorothiazide using bioadhesive polymers. J. Phar. Sci 74 (4):406–411.
   PubMed Web of Science ®Google Scholar
• A. Ludwig. (2005). The use of mucoadhesive polymers in ocular drug delivery. Adv. drug deliv. rev 57:1595–1639.
   PubMed Web of Science ®Google Scholar
• R. A. Maguire, V. R. Zacharopoulos, and D. M. Phillips. (1998). Carrageenan-based nonoxynol-9 spermicides for prevention of sexually transmitted infections. Sex. Transm. Dis 25:494–500.
   PubMed Web of Science ®Google Scholar
• L. Martin, C. G. Wilson, F. Koosha, and I. F. Uchegbu. (2003). Sustained buccal delivery of the hydrophobic drug denbufylline using physically cross-linked palmitoyl glycol chitosan hydrogels. Eur. J. Pharm. Biopharm 55:35–45.
   PubMed Web of Science ®Google Scholar
• C. Meignant, C. Vieillard-Baron, and S. Verdier. (1999). Synergistic pharmaceutical combination containing imidazole derivatives for locally treating vulvovaginitis and vaginosis. WO 99–FR973.
   Google Scholar
• A. G. Mikos, and N. A. Peppas. (1986). Systems for controlled drug delivery of drugs: V. Bioadhesive systems. S.T.P. Pharma Sci 2:705–716.
   Google Scholar
• A. G. Mikos, and N. A. Peppas. (1990). Scaling concepts and molecular theories of adhesion of synthetic polymers to glycoprotenic networks. In V. Lenaerts, and R. Gurny (Eds.). Bioadhesive drug delivery systems (p. 25). Boca Raton, FL: CRC Press.
   Google Scholar
• M. Minabe, K. Takeuchi, T. Tamura, T. Hori, and T. Umemoto. (1989). Subgingival administration of tetracycline on a collagen film. J. Periodontol 60:552–556.
   PubMed Web of Science ®Google Scholar
• P. Minghetti, B. Pacchetti, L. Montanari, C. Ronchi, and F. Berlati. (1997). Buccoadhesive tablets for the slow delivery of cetylpyridinium chloride: design and in vitro/in vivo analysis. Boll. Chim. Farm 136:543–548.
   PubMedGoogle Scholar
• M. I. Mohamed, and N. D. Mortada. (2000). Development and characterization of a buccoadhesive dosage form of terbutaline sulphate, Mansoura. J. Pharm. Sci 16:69–81.
   Google Scholar
• F. A. Mohammed, and H. Khedr. (2003). Preparation and in vitro/in vivo evaluation of the buccal bioadhesive properties of slow release tablets containing miconazole nitrate. Drug Dev. Ind. Pharm 29:321–337.
   PubMed Web of Science ®Google Scholar
• S. A. Mortazavi, B. G. Carpenter, and J. D. Smart. (1994). Factors influencing gel strengthening at the mucoadhesive-mucous interface. J. Pharm. Pharmacol 46:86–91.
   PubMed Web of Science ®Google Scholar
• S. A. Mortazavi, and J. D. Smart. (1993). Factors influencing gel-strengthening at the mucoadhesive–mucus interface. J. Pharm. Pharmacol 46:86–90.
   Web of Science ®Google Scholar
• N. A. Nafee, N. A. Boraie, F. A. Ismail, and L. M. Mortada. (2003). Design and characterization of mucoadhesive buccal patches containing cetylpyridinium chloride. Acta Pharm 53:199–212.
   PubMedGoogle Scholar
• N. A. Nafee, F. A. Ismail, N. A. Boraie, and L. M. Mortada. (2003). Mucoadhesive buccal patches of miconazole nitrate: in vitro/in vivo performance and effect of ageing. Int. J. Pharm 264:1–14.
   PubMed Web of Science ®Google Scholar
• K. Nakamura, Y. Maitani, A. M. Lowman, K. Takayama, N. A. Peppas, and T. Nagai. (1999). Uptake and release of budesonide from mucoadhesive, pH-sensitive copolymers and their application to nasal delivery. J. Control. Release 61:329–335.
   PubMed Web of Science ®Google Scholar
• S. Nakane, M. Kakumoto, K. Yukimatsu, and Y. W. Chien. (1996). Oramucosal delivery of LHRH: Pharmacokinetic studies of controlled and enhanced transmucosal permeation. Pharm. Dev. Technol 1:251–259.
   PubMedGoogle Scholar
• M. Oguchi, N. Shikama, S. Sasaki, K. Gomi, Y. Katsuyama, S. Ohta, M. Hori, K. Takei, K. Arakawa, and S. Sone. (1998). Mucosaadhesive water-soluble polymer film for treatment of acute radiation-induced oral mucositis. Int. J. Radiat. Oncol. Biol. Phys 40:1033–1037.
   PubMed Web of Science ®Google Scholar
• H. Okamoto, T. Nakamori, Y. Arakawa, K. Iida, and K. Danjo. (2002). Development of polymer film dosage forms of lidocaine for buccal administration: II. Comparison of preparation methods. J. Pharm. Sci 91:2424–2432.
   PubMed Web of Science ®Google Scholar
• H. Okamoto, H. Taguchi, K. Iida, and K. Danjo. (2001). Development of polymer film dosage forms of lidocaine for buccal administration: I. Penetration rate and release rate. J. Control. Release 77:253–260.
   PubMed Web of Science ®Google Scholar
• N. A. Osipova, G. A. Novikov, M. S. Vetsheva, B. M. Prokhorov, V. A. Beresnev, N. A. Loseva, S. Iu. Zemskaya, and T. A. Smolina. (1994). Prosidol, a new Russian narcotic analgesic: The first results in oncology. Anesteziol. Reanimatol 17:53–57.
   Google Scholar
• D. H. Owen, E. N. Dunmire, A. M. Plenys, and D. F. Katz. (1999). Factors influencing nonoxynol-9 permeation and bioactivity in cervical mucus. J. Control. Release 60:23–34.
   PubMed Web of Science ®Google Scholar
• Y. Ozsoy, T. Tuncel, A. Can, N. Akev, S. Birteksoz, and A. Gerceker. (2000). In vivo studies on nasal preparations of ciprofloxacin hydrochloride. Pharmazie 55:607–609.
   PubMed Web of Science ®Google Scholar
• C. R. Park, and D. L. Munday. (2002). Development and evaluation of a biphasic buccal adhesive tablet for nicotine replacement therapy. Int. J. Pharm 237:215–226.
   PubMed Web of Science ®Google Scholar
• H. Park, and J. R. Robinson. (1985a). In vitro assessment of bioadesive dosage forms. J. Control. Rel 2:47.
   Google Scholar
• H. Park, and J. R. Robinson. (1985b). Physico-chemical properties of water insoluble polymers important to mucin epithelial adhesion. J. Control. Release 2:47–57.
   Google Scholar
• J. S. Park, J. I. Yoon, H. Li, D. C. Moon, and K. Han. (2003). Buccal mucosal ulcer healing effect of rhEGF/Eudispert hv hydrogel. Arch. Pharm. Res 26:659–665.
   PubMed Web of Science ®Google Scholar
• K. Park. (1989). A new approach to study mucoadhesion: Colloidal gold staining. Int. J. Pharm 53:209–217.
   Web of Science ®Google Scholar
• K. Park, and J. R. Robinson. (1984). Bioadhesive polymers as platforms for oral controlled drug delivery: Method to study bioadhesion. Int. J. Pharm 19 (1):107–127.
   Google Scholar
• B. Parodi, E. Russo, P. Gatti, S. Cafaggi, and G. Bignardi. (1999). Development and in vitro evaluation of buccoadhesive tablets using a new model substrate for bioadhesion measures: the eggshell membrane. Drug Dev. Ind. Pharm 25:289–295.
   PubMed Web of Science ®Google Scholar
• N. Parvez, A. Ahuja, and R. K. Khar. (2002). Development and evaluation of muco-adhesive buccal tablets of lignocaine hydrochloride. Indian J. Pharm. Sci 64:563–567.
   Google Scholar
• S. B. Patil, R. S. R. Murthy, H. S. Mahajan, R. D. Wagh, and S. G. Gattani. (2006). Mucoadhesive polymers: Means of improving drug delivery. Pharm. times 38 (4):25–30.
   Google Scholar
• T. F. Patton, and J .R. Robinson. (1976). Ocular evaluation of polyvinylalcohol vehicle in rabbits. J. Pharm. Sci 65:1295–1301.
   PubMed Web of Science ®Google Scholar
• N. A. Peppas, and P. A. Buri. (1985). Surface, interfacial and molecular aspects of polymer bioadhesion on soft tissues. J. Control. Release 2:257–275.
   Google Scholar
• L. Perioli, V. Ambrogi, D. Rubini, S. Giovagnoli, M. Ricci, P. Blasi, and C. Rossi. (2004). Novel mucoadhesive buccal formulation containing metronidazole for the treatment of periodontal disease. J. Control. Release 95:521–533.
   PubMed Web of Science ®Google Scholar
• M. Petelin, Z. Pavlica, S. Bizimoska, and M. Sentjure. (2004). In vivo study of different ointments for drug delivery in to oral mucosa EPR oximetry. Int. J. Pharm 270:83–91.
   PubMed Web of Science ®Google Scholar
• M. Preda, and S. E. Leucuta. (2003). Oxprenolol-loaded bioadhesive microspheres: preparation and in vitro/in vivo characterization. J. Microencapsul 20:777–789.
   PubMed Web of Science ®Google Scholar
• M. Quadir, H. Zia, and T. E. Needham. (2000). Development and evaluation of nasal formulations of ketorolac. Drug Deliv 7:223–229.
   PubMed Web of Science ®Google Scholar
• P. S. Rajinikanth, C. Sankar, and B. Mishra. (2003). Sodium alginate microspheres of metoprolol tartrate for intranasal systemic delivery: development and evaluation. Drug Deliv 10:21–28.
   PubMed Web of Science ®Google Scholar
• C. Remuñán-López, A. Portero, J. L. Vila-Jato, and M. J. Alonso. (1998). Design and evaluation of chitosan/ethylcellulose mucoadhesive bilayered devices for buccal drug delivery. J. Control. Release 55:143–152.
   PubMed Web of Science ®Google Scholar
• G. J. Rhee, D. K. Lee, K. H. Sin, and C. B. Park. (1999). Formulation and pharmaceutical properties of mucoadhesive films containing dipotassium glycyrrhizate. J. Korean Pharm. Sci 29:127–136.
   Google Scholar
• J. L. Richardson, and L. Illum. (1992). The vaginal route of peptide and protein drug delivery. Adv. Drug Deliv. Rev 8:341–366.
   Web of Science ®Google Scholar
• J. L. Richardson, and T. I. Trevor. (1999). Vaginal delivery of calcitonin by hyaluronic acid formulations. Drugs Pharm. Sci 98:563–599.
   Google Scholar
• W. A. Ritschel, G. B. Ritschel, H. Forusz, and M. Kraeling. (1989). Buccal absorption of insulin in the dog. Res. Commun. Chem. Pathol. Pharmacol 63:53–67.
   PubMedGoogle Scholar
• R. J. M. Ross, A. Jabbar, T. H. Jones, B. Roberts, K. Dunkley, J. Hall, A. Long, H. Levine, and D. R. Cullen. (2004). Pharmacokinetics and tolerability of a bioadhesive buccal testosterone tablet in hypogonadal men. Eur. J. Endocrinol 150:57–63.
   PubMed Web of Science ®Google Scholar
• S. Rossi, G. Sandri, F. Ferrari, M. C. Bonferoni, and C. Caramella. (2003). Buccal delivery of acyclovir from films based on chitosan and polyacrylic acid. Pharm. Dev. Technol 8:199–208.
   PubMed Web of Science ®Google Scholar
• M. F. Saettone, S. Burgalassi, and P. Chetoni. (1999). Ocular bioadhesive drug delivery system. In E. Mathiowitz, D. E. Chickering, and C. M. Lehr(Eds.). Bioahesive drug delivery systems. Fundamentals, Novel Approaches and Development (pp. 601–640). New York: Marcel Dekker, Inc.
   Google Scholar
• M. F. Saettone, S. Burgalassi, and P. Chetoni. (2005). Ocular bioadhesive drug delivery systems. In E. Mathiowitz, D. E. Chickering, and C. -M. Lehr(Eds.). Bioadhesive drug delivery systems. Fundamentals, Novel Approaches and Development (pp. 601–640). New York: Marcel Dekker, Inc.
   Google Scholar
• M. F. Saettone, B. Giannaccini, A. Guiducci, F. Marca, and G. Tota. (1985). Polymer effects on ocular bioavailability: II. The influence of benzalkonium chloride on the mydriatic response of tropicamide in different polymeric vehicles. Int. J. Pharm 25:73–83.
   Web of Science ®Google Scholar
• M. F. Saettone, B. Giannaccini, S. Ravecca, F. La Marca, and G. Tota. (1984). Polymer effects on ocular bioavailability—the influence of different liquid vehicles on the mydriatic response of tropicamide in humans and rabbits. Int. J. Pharm 20:187–202.
   Web of Science ®Google Scholar
• M. F. Saettone, B. Giannaccini, A. Teneggi, P. Savigni, and N. Tellini. (1982). Vehicle effects on ophthalmic bioavailability: The influence of different polymers on the activity of pilocarpine in rabbit and man. J. Pharm. Pharmacol 34:464–466.
   PubMed Web of Science ®Google Scholar
• A. P. Sam, J. T. Van Dan Heuij, and J. Tukker. (1989). Mucoadhesion of both film-forming and non-film forming polymeric materials as evaluated with the Wilhelmy plate method. Int. J. Pharm 53:97–105.
   Google Scholar
• C. Sankar, M. Rani, A. K. Srivastava, and B. Mishra. (2001). Chitosan based pentazocine microspheres for intranasal systemic delivery: development and biopharmaceutical evaluation. Pharmazie 56:223–226.
   PubMed Web of Science ®Google Scholar
• T. Save, M. U. Shah, A. R. Ghamande, and P. Venkitachalam. (1994). Comparative study of buccoadhesive formulations and sublingual capsules of nifedipine. J. Pharm. Pharmacol 46:192–195.
   PubMed Web of Science ®Google Scholar
• W. Schurr, B. Knoll, R. Ziegler, R. Anders, and H. P. Merkle. (1985). Comparative study of intravenous, nasal, oral and buccal TRH administration among healthy subjects. J. Endocrinol. Invest 8:41–44.
   PubMed Web of Science ®Google Scholar
• S. Σenel, G. İkinci, S. Kas, A. Yousefi-Rad, M. F. Sargon, and A. A. Hincal. (2000). Chitosan films and hydrogels of chlorhexidine gluconate for oral mucosal delivery. Int. J. Pharm 193:197–203.
   PubMed Web of Science ®Google Scholar
• S. -C. Shin, and J. -Y. Kim. (2000). Enhanced permeation of triamcinolone acetonide through the buccal mucosa. Eur. J. Pharm. Biopharm 50:217–220.
   PubMed Web of Science ®Google Scholar
• S. -C. Shin, J. -P. Bum, and J. -S. Choi. (2000). Enhanced bioavailability by buccal administration of triamcinolone acetonide from the bioadhesive gels in rabbits. Int. J. Pharm 209:37–43.
   PubMed Web of Science ®Google Scholar
• A. H. Shojaei, B. Berner, and X. Li. (1998). Transbuccal delivery of acyclovir: I. In vitro determination of routes of buccal transport. Pharm. Res 15:1182–1188.
   PubMed Web of Science ®Google Scholar
• A. H. Shojaei, S. -L. Zhuo, and X. Li. (1998). Transbuccal delivery of acyclovir (II): Feasibility, system design, and in vitro permeation studies. J. Pharm. Pharm. Sci 1:66–73.
   PubMedGoogle Scholar
• B. Singh, and N. Ahuja. (2002). Development of controlled-release buccoadhesive hydrophilic matrices of diltiazem hydrochloride: Optimization of bioadhesion, dissolution, and diffusion parameters. Drug Dev. Ind. Pharm 28:431–442.
   PubMed Web of Science ®Google Scholar
• A. K. Singh, N. Bhardwaj, and A. Bhatnagar. (2004). Pharmacoscintigraphy: An unexplored modality in India. Ind. J. Pharm. Sci 66 (1):18–25.
   Google Scholar
• P. Sinswat, and P. Tengamnuay. (2003). Enhancing effect of chitosan on nasal absorption of salmon calcitonin in rats: Comparison with hydroxypropyl-beta and dimethyl-beta-cyclodextrins. Int. J. Pharm 257:15–22.
   PubMed Web of Science ®Google Scholar
• J. D. Smart, and IW. Kellaway. (1982). In-vitro techniques for measuring mucoadhesion. J. Pharm. Pharmacol 34:70.
   Google Scholar
• J. D. Smart, I. W. Kellaway, and H. E. C. Worthington. (1984). An in vitro investigation of mucosa-adhesive materials for use in controlled drug delivery. J. Pharm. Pharmacol 36:295–299.
   PubMed Web of Science ®Google Scholar
• S. S. Strickland, G. V. Veena, P. J. Houghton, S. C. Stanford, and A. V. Kurpad. (2003). Areca nut, energy metabolism and hunger in Asian men. Ann. Hum. Biol 30:26–52.
   PubMed Web of Science ®Google Scholar
• Y. Suzuki, and Y. Makino. (1999). Mucosal drug delivery using cellulose derivatives as a functional polymer. J. Control. Release 62:101–107.
   PubMed Web of Science ®Google Scholar
• R. Talukdar, and R. Fassihi. (2004). Gastroretentive delivery systems: A mini review. Temple School of Pharmacy. Philadelphia, Pennsylvania. USA. Drug Dev. Ind. Pharm 30 (10):1019–1028.
   PubMedGoogle Scholar
• Y. T. F. Tan, K. K. Peh, and O. Al-Hanbali. (2000). Effect of Carbopol and polyvinylpyrrolidone on the mechanical, rheological, and release properties of bioadhesive polyethylene glycol gels. AAPS Pharm. Sci. Tech 1:E24.
   PubMedGoogle Scholar
• C. L. C. Teng, and P. Buri. (1987). Mechanistic studies in the simultaneous flow and adsorption of polymer-coated latex particles on intestinal mucus. I. Methods and physical model development. J. Control. Rel 6:133.
   Google Scholar
• D. Tiwari, D. Goldman, R. Sause, and P. L. Madan. (1999). Evaluation of polyoxyethylene homopolymers for buccal bioadhesive drug delivery device formulations. AAPS Pharm. Sci 1:E13.
   PubMedGoogle Scholar
• D. Tiwari, D. Goldman, C. Town, R. Sause, and P. L. Madan. (1999). In vitro–in vivo evaluation of a controlled release buccal bioadhesive device for oral drug delivery. Pharm. Res 16:1775–1780.
   PubMed Web of Science ®Google Scholar
• J. H. Trueblood, R. M. Rossomondo, W. H. Carlton, and L. A. Wilson. (1975). Corneal contact times of ophthalmic vehicles. Evaluation by microscintigraphy. Arch. Ophthalmol 93:127–130.
   PubMed Web of Science ®Google Scholar
• K. Tsutsumi, Y. Obata, T. Nagai, T. Loftsson, and K. Takayama. (2002). Buccal absorption of ergotamine tartrate using the bioadhesive tablet system in guinea-pigs. Int. J. Pharm 238:161–170.
   PubMed Web of Science ®Google Scholar
• M. I. Ugwoke, R. U. Agu, N. Verbeke, and R. Kinget. (2005). Nasal mucoadhesive drug delivery: Background, applications, trends and future perspectives. Adv. drug Deliv. Rev 57:1640–1665.
   PubMed Web of Science ®Google Scholar
• M. I. Ugwoke, G. Kaufmann, N. Verbeke, and R. Kinget. (2000). Intranasal bioavailability of apomorphine from carboxymethylcellulose-based drug delivery systems. Int. J. Pharm 202:125–131.
   PubMed Web of Science ®Google Scholar
• M. I. Ugwoke, E. Sam, G. Van Den Mooter, N. Verbeke, and R. Kinget. (1999). Bioavailability of apomorphine following intranasal administration of mucoadhesive drug delivery systems in rabbits. Eur. J. Pharm. Sci 9:213–219.
   PubMed Web of Science ®Google Scholar
• C. Valenta. (2005). The use of mucoadhesive polymers in vaginal delivery. Adv. Drug Deliv. Rev 57:1692–1712.
   PubMed Web of Science ®Google Scholar
• J. Van Roey, M. Haxaire, M. Kamya, I. Lwanga, and E. Katabira. (2004). Comparative efficacy of topical therapy with a slow-release mucoadhesive buccal tablet containing miconazole nitrate versus systemic therapy with ketoconazole in HIV-positive patients with oropharyngeal candidiasis. J. Acquir. Immune Defic. Syndr 35:144–150.
   PubMed Web of Science ®Google Scholar
• J. Varshosaz, and Z. Dehghan. (2002). Development and characterization of buccoadhesive nifedipine tablets. Eur. J. Pharm. Biopharm 54:135–141.
   PubMed Web of Science ®Google Scholar
• A. H. C. Vinholis, L. C. de Figueiredo, E. MarcantonioJr., R. A. C. Marcantonio, S. L. S. Salvador, and G. Goissis. (2001). Subgingival utilization of a 1% chlorhexidine collagen gel for the treatment of periodontal pockets. A clinical and microbiological study. Braz. Dent. J 12:209–213.
   PubMedGoogle Scholar
• N. Vivien-Castioni, R. Gurny, P. Baehni, and V. Kaltsatos. (2000). Salivary fluoride concentrations following applications of bioadhesive tablets and mouthrinses. Eur. J. Pharm. Biopharm 49:27–33.
   PubMed Web of Science ®Google Scholar
• J. Voorspoels, J. -P. Remon, W. Eechaute, and W. De Sy. (1996). Buccal absorption of testosterone and its esters using a bioadhesive tablet in dogs. Pharm. Res 13:1228–1232.
   PubMed Web of Science ®Google Scholar
• J. W. Wallace. (1990). Cellulose derivatives and natural products utilised. In J. Swarback, and J. C. Boylan(Eds.). Encyclopaedia of pharmaceutical technology (pp. 319–337). New York: Macrel Dekkar.
   Google Scholar
• M. Witvrouw, and E. De Clercq. (1997). Sulfated polysaccharides extracted from sea algae as potential antiviral drugs. Gen. Pharmacol 29:497–511.
   PubMedGoogle Scholar
• C. F. Wong, K. H. Yuen, and K. K. Peh. (1999). Formulation and evaluation of controlled release Eudragit buccal patches. Int. J. Pharm 178:11–22.
   PubMed Web of Science ®Google Scholar
• C. S. Yong, J. -H. Jung, J. -D. Rhee, C. -K. Kim, and H. -G. Choi. (2001). Physicochemical characterization and evaluation of buccal adhesive tablets containing omeprazole. Drug Dev. Ind. Pharm 27:447–455.
   PubMed Web of Science ®Google Scholar
• V. R. Zacharopoulos, and D. M. Phillips. (1997). Vaginal formulations of carrageenan protect mice from herpes simplex virus infection. Clin. Diagn. Lab. Immunol 4:465–468.
   PubMedGoogle Scholar